scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1043916979 |
P356 | DOI | 10.1007/S00216-015-8828-6 |
P698 | PubMed publication ID | 26108532 |
P50 | author | Simon D. Brandt | Q47819756 |
Hans H. Maurer | Q52760572 | ||
P2093 | author name string | Markus R Meyer | |
Volker Auwärter | |||
Andreas G Helfer | |||
Julian A Michely | |||
Achim T Caspar | |||
P4510 | describes a project that uses | gas chromatography-mass spectrometry | Q873009 |
P433 | issue | 22 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6697-6719 | |
P577 | publication date | 2015-06-25 | |
P1433 | published in | Analytical and Bioanalytical Chemistry | Q2845280 |
P1476 | title | Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS | |
P478 | volume | 407 |
Q55383928 | 25C-NBOMe Ingestion. |
Q39569585 | 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry |
Q93384911 | Automated optimization of XCMS parameters for improved peak picking of liquid chromatography-mass spectrometry data using the coefficient of variation and parameter sweeping for untargeted metabolomics |
Q53063534 | Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH. |
Q47191000 | Different in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse. |
Q34510789 | Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MSn , and LC-HR-MSn. |
Q64106117 | In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)--(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography⁻Mass Spectrometry |
Q35779974 | In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS. |
Q93273519 | Investigating the ability of the microbial model Cunninghamella elegans for the metabolism of synthetic tryptamines |
Q39666362 | Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans? |
Q48362650 | Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MSn , and LC-HR-MS/MS. |
Q92041409 | Multimodal imaging of hallucinogens 25C- and 25I-NBOMe on blotter papers |
Q90344547 | NBOMes-Highly Potent and Toxic Alternatives of LSD |
Q91833440 | Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings |
Search more.